Niflumic acid
Synonym(s):2-(α,α,α-Trifluoro-m-toluidino)nicotinic acid;2-[3-(Trifluoromethyl)anilino]nicotinic acid
- CAS NO.:4394-00-7
- Empirical Formula: C13H9F3N2O2
- Molecular Weight: 282.22
- MDL number: MFCD00010569
- EINECS: 224-516-2
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-09 21:40:10
What is Niflumic acid?
Chemical properties
Crystalline Solid
Originator
Nifluril,U.P.S.A.,France,1968
The Uses of Niflumic acid
Niflumic acid is used for the exact same indications as the drugs described above. Synonyms for this drug are actol, flunir, nifluril, and others.
The Uses of Niflumic acid
Anti-inflammatory. Selective cyclooxygenase-2 (COX-2) inhibitor
The Uses of Niflumic acid
analgesic, antiinflammatory
What are the applications of Application
Niflumic acid is a selective Cox-2 inhibitor and GPR35 activator
Definition
ChEBI: Niflumic acid is an aromatic carboxylic acid and a member of pyridines.
Manufacturing Process
Niflumic acid is prepared as follows: Nicotinic acid, m-trifluoromethylaniline, and potassium iodide are intimately mixed and heated on an oil bath at 140°C. The mixture melts to give a dark red liquid. The temperature of the oil bath is allowed to fall to 100°C and is maintained at this temperature for an hour and a half. The mixture puffs up and forms a yellow crystalline mass. After cooling to ordinary temperature, this mass is ground up in a mortar and extracted several times with small volumes of ether to remove excess mtrifluoromethylaniline. The residue is then washed twice with 10 ml of distilled water to remove m-trifluoromethylaniline hydrochloride and potassium iodide, and finally twice with 10 ml of 95% alcohol to remove colored resinous contaminants. After drying at 100°C, 2-(m-trifluoromethylanilino)nicotinic acid is obtained as pale yellow needles (from 70% ethanol) melting at 204°C (Kofler block).
Therapeutic Function
Antiinflammatory
Trade name
Actol (Mayrhofer, Austria; Upsamedica, Spain), Donalgin (Gedeon Richter, Hungary), Livornex (Genepharm, Greece), Ni- flam (Upsamedica, Italy), Nifluril (UPSA, France; Upsamedica, Belgium, Switzerland, Portugal).
Biochem/physiol Actions
Niflumic acid (NFA), a γ-aminobutyric acid type A receptor (GABAARs) antagonist is a non-steroidal anti-inflammatory drug (NSAID) and it belongs to the fenamate class. It is also a blocker of chloride ion channel and a calcium-activated chloride channel (CaCC) inhibitor. NFA possesses anti-inflammatory property and is useful in treating rheumatic disorders. It is also an inhibitor of N-methyl-D-aspartate receptor and glycine receptor. NFA also inhibits enzymes associated with the prostaglandins synthesis.
Side Effects
Niflumic acid has been used effectively to treat rheumatoid arthritis, psoriatic arthritis, and hypertrophic osteoarthritis of the hip and knee. Gastric complications are the chief adverse effects of this drug.
Synthesis
Niflumic acid, 2-3-(trifluoromethyl)anilino nicotinic acid (3.2.21), is synthesized either by the reaction of 2-chloronicotinic acid with 3-trifluoromethylaniline [84¨C86], or 2-aminonicotinic acid with 1-bromo-3-trifluoromethylbenzene [87].
Properties of Niflumic acid
Melting point: | 203-204 °C |
Boiling point: | 378.0±42.0 °C(Predicted) |
Density | 1.3935 (estimate) |
storage temp. | 2-8°C |
solubility | Soluble in ethanol (~50 mg/ml), acetone (50 mg/ml, Clear to Slightly Hazy, Yellow), methanol (~50 mg/ml), DMSO (56 mg/ml at 25°C), and acetonitrile (~50 mg/ml). |
form | neat |
pka | pKa 2.26 ± 0.08;4.44± 0.03(H2O,t =25±0.1,I=0.01(NaCl))(Approximate) |
form | Solid |
color | Light orange to Yellow to Green |
Water Solubility | 19mg/L(room temperature) |
Sensitive | Light Sensitive |
Merck | 14,6531 |
Stability: | Stable, but may discolour in light. Incompatible with strong oxidizing agents. Hygroscopic. |
NIST Chemistry Reference | Niflumic acid(4394-00-7) |
EPA Substance Registry System | 3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]- (4394-00-7) |
Safety information for Niflumic acid
Signal word | Danger |
Pictogram(s) |
Skull and Crossbones Acute Toxicity GHS06 |
GHS Hazard Statements |
H301:Acute toxicity,oral H413:Hazardous to the aquatic environment, long-term hazard |
Precautionary Statement Codes |
P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P273:Avoid release to the environment. P301+P310:IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P405:Store locked up. P501:Dispose of contents/container to..… |
Computed Descriptors for Niflumic acid
InChIKey | JZFPYUNJRRFVQU-UHFFFAOYSA-N |
New Products
ALUMINIUM IODIDE 100 GM BUFFER CAPSULE PH 7.0 - 10 CAP BUFFER SOLUTION PH 9.5 (BORATE) EZEE BLUE GEL STAINER BORAX CARMINE (GRENACHERS ALCOHOLIC) POTASSIUM IODATE - IODIDE SOLN 0.1 N Dabigatran Acyl-O3-D-Glucuronide Trifluoroacetic Acid Salt Isofolic Acid Dabigatran 2-O-acylglucuronide metabolite Dabigatran Acyl-?-D- glucuronide Trifluroacetic Acid Erythromycin EP Impurity A Desloratidine Related Compound ARelated products of tetrahydrofuran
You may like
-
Niflumic Acid CAS 4394-00-7View Details
4394-00-7 -
Niflumic acid 95% CAS 4394-00-7View Details
4394-00-7 -
Niflumic acid CAS 4394-00-7View Details
4394-00-7 -
Dechloro DesloratadineView Details
-
Dehydro DesloratadineView Details
-
Edoxaban Impurity 57View Details
2089454-69-1 -
Empagliflozin Bromo ImpurityView Details
-
Ipratropium EP Impurity BView Details
58073-59-9